This inventor holds 1 USPTO granted patent. Top assignee: Changchun Institute of Biological Products, Ministry of Public Health. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Hui Lin - Innovator in Hepatitis A Vaccine Development
Introduction
Hui Lin is a prominent inventor based in Changchun, China. He has made significant contributions to the field of vaccine development, particularly in the area of hepatitis A. His innovative work has the potential to improve public health outcomes through enhanced vaccine stability and storage.
Latest Patents
Hui Lin holds a patent for a freeze-dried hepatitis A attenuated live vaccine and its stabilizer. This invention relates to a lyophilized attenuated hepatitis A vaccine that can be stored at ambient temperature for extended periods. The patent also includes a method for producing this vaccine, along with a stabilizer that improves the thermostability of the lyophilized live vaccine during processing and storage.
Career Highlights
Hui Lin is affiliated with the Changchun Institute of Biological Products, which operates under the Ministry of Public Health. His work at this institute has been pivotal in advancing vaccine technology and ensuring the availability of effective vaccines for hepatitis A.
Collaborations
Hui Lin has collaborated with notable colleagues, including Baosheng Xie and Zongming Song. Their combined expertise has contributed to the successful development of innovative vaccine solutions.
Conclusion
Hui Lin's contributions to vaccine development, particularly in the area of hepatitis A, highlight his role as an important inventor in the field. His patented innovations promise to enhance vaccine stability and accessibility, ultimately benefiting public health.